相关实验视频

Updated: May 28, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

路径特异性解绑自由能量概况里托纳维尔与HIV-1蛋白酶解离

Emily Vig¹, Jianan Sun², Chia-En A Chang^1,2

¹Department of Biochemistry and Molecular Biology, University of California Riverside, Riverside, California 92521, United States.

|February 10, 2025

概括

这项研究揭示了利托纳维尔脱离艾滋病毒蛋白酶的不同途径,其中途径A最常见. 蛋白质动态和突变效应与途径A相关.

科学领域:

计算化学是一种计算化学.
分子动力学模拟的模拟.
生物物理学的生物物理.

背景情况:

蛋白质药物识别对于药物的有效性和选择性至关重要.
了解药物结合/解结合机制需要分析自由能量景观和分子间相互作用.
这些知识有助于开发改进的药物和解释突变效应.

研究的目的:

研究里托纳维尔与艾滋病毒蛋白酶 (HIVp) 的解离途径.
使用里程碑理论构建一个解约的自由能源景观.
阐明蛋白质动态和分子间相互作用在药物解结中的作用.

主要方法:

加快分子动力学 (MD) 模拟以建模解结轨迹.
主要组件分析 (PCA) 用于缩小维度.
里程碑理论应用于经典的MD运行与明确的水,以建立自由能源的景观.

主要成果:

鉴定了三种不同的利托纳维尔解结路径 (A-C).
途径A占解离轨迹的50%以上,途径之间具有类似的结合自由能量.
途径A涉及广泛的残留-残留相关网络,包括突变残留物,影响蛋白质运动.

结论:

路径A的优势归因于其广泛的相关性网络,与路径B和C不同.
结合显著影响片区域的运动,并影响计算的结合自由能量.
该研究提出了一种用于估计连接体结合的自由能量的新策略,并强调了药物解结中的短暂相互作用的重要性.

更多相关视频

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

相关概念视频

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...